Circulating autoantibodies to human and rat androgen receptors are present at high titers in the blood sera of some patients with prostate diseases. The antibodies from some serum samples were associated with a purified IgG fraction and interacted with the 3.8S cytosolic androgen-receptor complexes of rat ventral prostate to form 9-to 12S units. Other serum samples, however, formed 14-to 19S units, suggesting that other immunoglobulins might be involved. In the presence of an anti-human immunoglobulin as a second antibody, the androgen-receptor-antibody complexes could be immunoprecipitated. The antibodies interacted with the nuclear and the cytosolic androgen-receptor complexes, either the DNA-binding or the nonbinding form, but not with receptors for estradiol, progestin, or dexamethasone from a variety of sources. Human testosterone/estradiol-binding globulin, rat epididymal androgen-binding protein, or rat prostate a-protein (a nonreceptor steroid-binding protein) also did not interact with the antibodies to form immunoprecipitates. About 37% of male and 3% of female serum samples screened had significant antibody titer. The chance ofrinding serum with a high titer is much better in males older than 66 years than in the younger males or females at all ages. The presence of the high-titer antibodies may make it possible to prepare monoclonal antibodies to androgen receptors without purification of the receptors for immunization.Steroid receptors are usually characterized by their ability to bind radioactive ligands. The isolation of polyclonal and monoclonal antibodies to estrogen (1, 2), glucocorticoid (3-5), and progestin (6-8) receptors in recent years, however, has provided alternative means to study these hormone receptors. An antibody against androgen receptors, however, has not been produced, mainly because of the difficulty in obtaining androgen receptors in sufficiently pure form and in amounts needed for efficient immunization. In this report, we show that anti-androgen receptor antibodies are present in high titers in blood sera of some male patients having clinical prostate problems.
MATERIALS AND METHODSMaterials. 5a- [1,2,3,4,5,6,16,17-3H(N)